Instead of the traditional professional breakfasts, this year we decided to organize professional afterworks from 7pm to 8pm on Zoom !


Every two months, the following associations: YR2I, ADIC, JeCCO, Stapa, ADELIH, BioDocs and Doc’Up, invite you to the Professionnal Afterworks where you can meet people who left academia after their PhD: clinical research associates (attachés de recherche clinique), consultants, scientific communcation, journalism…

Each session is divided in two parts, first two round tables, followed by a free time in order to discover more precisely the experience of each guest and discover new career opportunities after your PhD.

Here is the Planning for the year 2021 :

      • 3rd of March 2021
      • 4th of May 2021
      • 28th of June 2021
      • 23th of September 2021
      • 24th of November 2021

Valentina Grampa Courtière defended her PhD on renal ciliopathies at the Imagine Institute in 2015. Following her 2 post-docs at the Imagine Institute and then at the Institut du Fer à Moulin in Paris, she joined Ipsen which is a pharmaceutical company 2 years ago. After having had several different positions in medical affairs within this company, Valentina is now Medical Science Liaison, with an expertise on anti-cancer treatments for kidney and prostate, and is in charge of the Auvergne Rhône – Alpes and Bourgogne Franche Comté regions.

Nathan Beckouche obtained his PhD in 2013, after spending 3 years at the Collège de France working on angiogenesis. He then did a post-doc at the UCSF Medical Center in San Francisco before leaving the classical academic path. After working for a few months in the private company Alexion as a project manager on drug discovery, he was for more than 3 years a self-employed consultant in the same field of expertise. Nathan is now co-founder and director of pre-clinical development at AtmosR, a biotech company developing innovative treatments for rare central nervous system diseases.

Matthieu Lemasson has defended a thesis in Dr. Arielle ROSENBERG lab in 2015 on the diversion of hepatocyte lipid metabolism by HCV (example of lysophosphatidylcholine acyltransférase 1) followed by a postdoctoral contract in this same lab. After that, he has worked as researcher engineer in Institut National de la Transfusion Sanguine (INTS, Paris) on the identification of antisense oligonucleotides antiviral mechanism on the viral particle secretion of HBV and HDV. A novel researcher engineer has followed in the company Sleep Apnea Innovation (SABI, ROMAINVILLE) on the identification of molecular markers of sleep apnea to develop clinical diagnostic kits. Now he is study director in Texcell, a company specialized on viral safety. 

Renaud Pourpre did his PhD at INRAE (Paris-Saclay) on epigenetics consequences of bacterial infections and defended in 2019. During his PhD, he helped organize Science outreach events such as the “Pint of Science Festival”. After graduating, he followed his passion for Science outreach; first in the French Government as a project manager in the Ministry of Research and Higher Education, then as a freelance communicator specialized in audio and video. He manages two podcasts, “The Lonely Pipette”, that he hosts together with Jonathan Weitzman and that is geared towards scientists, and “Quand le Crime parle”, a crime solving podcast geared towards a wider audience. He is now also working on the launch of his new project combining a documentary and an immersive exhibition, “Cell Worlds”.

Fanny Roth defended her PhD on oculopharyngeal muscular dystrophy at the Institute of Myology in 2019. Since then, she has been R&D project manager at The Healthy Aging Company. Her main tasks consist of fundraising, communication and business development tasks as well as pre-clinical tasks including assistance in planning laboratory experiments, monitoring and collecting results and writing activity reports.

 

Nikita Menezes obtained her PhD in bioinformatics at the ENS in 2019. Since then she has been a freelancer as a graphic designer and scientific illustrator. She offers her services to both the private and academic sector to create various illustrations, marketing materials, research data visualization and social media materials.

Christophe Martella has followed an academic track before starting a thesis on HTLV-1 associated Adult T cell leukemia and the transcriptional regulation involved in HTLV-1 provirus expression in the Retrovius, infection and latence lab in Cochin Institute. After that, he was recruited by Miltenyi Biotec as Clinical account manager cell and gene therapy. 

Benjamin Lassus defended his PhD in 2016 at Université Pierre et Marie Curie, during which he developed a high high-throughput microfluidic platform to study neuronal network calcium activity. He then did a Post-doctoral fellowship at CNRS, learning and optimizing microfluidic fabrication processes. He did a second post-doc at Columbia University (New York), where he worked on preventing the propagation of tauopathies in the CNS using microfluidic devices. He is now microfluidic scientist at HiFiBio, Paris.

Wilko Duprez began working in the pharmaceutical industry in the United States before undertaking a PhD in medicinal biochemistry in Australia. It was during his PhD that he discovered a vocation for science communication, hosting radio shows and science popularization events. After two short post-docs, he took the plunge and completed a Master’s degree in Science Communication at Imperial College London, which led to freelance work for the BBC. After a stint in Japan as a science communication officer for a young university, Wilko became a virtual reality science simulation director for Labster, a start-up based in Denmark. Since September 2020, Wilko has been the communications manager at Scipio bioscience, an RNA sequencing start-up based at the Brain Institute.

Florian Andrianiazy obtained his PhD in physics in 2015 after a CIFRE PhD carried out between the Thalès research centre and the laboratory of interface physics at the Ecole Polytechnique. After a long experience in the world of young researchers, he co-founded PhDTalent in 2017, whose objective is to accelerate the connection between the academic world and companies through freelance missions by researchers, recruitment and events.

Gweltas Odye defended his PhD on renal ciliopathies at the Imagine Institute in 2018. Since then, he has specialised in innovation consulting. At the interface of scientific and financing issues in terms of R&D and innovation, he is currently a consultant within the scientific pole dedicated to innovation financing of KPMG Avocats (KPMG Global), and assists French and international companies on a daily basis in financing their innovation projects.

Mathilde Maillard is in her third year of PhD in materials at the Mateis laboratory of Insa Lyon, a mixed research unit from Insa Lyon, Université Claude Bernard Lyon 1 and CNRS. In June 2020, she created her first podcast of “Bien dans ma thèse”, followed by a series of podcasts and videos to remedy the lack of information and support on the PhD. She quickly diversified by launching a website, a Youtube channel and Twitch and signed her partnership with Bpifrance to promote i-PhD, a competition intended for doctoral students.

Clément Gautier is director of external innovation in the department of rare diseases and neurosciences at Ipsen. He got his PhD in Biophysics in 2005 in the Laboratory for Optics and Biosciences at Ecole Polytechnique. He then spent five years as a postdoctoral fellow in Harvard Medical School at the Brigham and Women’s Hospital to study mitochondrial dysfunctions in animal and cellular models of Parkinson’s disease. Back in France, he worked at the Paris Brain Institute as a research scientist for two years. From there he was recruited at Servier where he led a team working in novel cellular assays for drug discovery and novel targets in neurodegenerative diseases. At Servier, he became director of external research and innovation in the Neuroscience department, before going into his actual position at Ipsen.

 

4th of May 2021

Nora Yahia. After a thesis in Immunology, on the immune response to the pandemic influenza vaccine, within the Inserm U1135 unit at the Pitié-Salpêtrière, Nora focused her professional project in the functions of supporting and valuing the fields of health research. She held the position of communications officer of the Cimi-Paris research center, before making a stint in the internal communications department of the pharmaceutical company Abbvie.

For the past three years, she has been responsible for monitoring and valuing scientific and medical projects at the HIV association, Sidaction. In this position, she monitors the scientific watch and the valuing of projects supported by the association. She also contributes to the animation of the research community and to the strengthening of the close links between Sidaction and the professional network in HIV/AIDS research, through coordination and participation in events involving the scientific community.

Lucile Veissier defended a thesis in quantum physics in 2013. Over a period of five years, she then completed two post-docs: one in Canada and another in France. After several applications for public position (CNRS and universities), the scarcity of positions got the better of her. The need for a radical change first got her on board in pastry making, then his selection in mediation training finally decided her for science journalism. Lucile now works for TheMetaNews, a media dedicated to researchers.

Zuzanna Andrzejewska. After her thesis at the University of Paris Descartes on a rare hereditary disease, cystinosis, Zuzanna was a post-doctoral fellow at the Pasteur Institute to study the role of stem cells during muscle regeneration. Zuzanna is Grant officer at Imagine since 2019. She assists the Institute’s researchers in identifying funding opportunities, preparing their funding applications and managing the funded projects.

Katy Billot. After defending her PhD on leukemia and associated epigenetic modifications in 2010, Katy completed a post-doctoral fellowship at the Cochin Institute and then obtained a position in the R&D department of a biotechnology company. She then did a formation in clinical research. She now works with a research team where she is in charge of coordinating clinical activities, recruiting patient cohorts, assembling databases and writing and preparing clinical research protocols

Benjamin Lassus defended his PhD in 2016 at Université Pierre et Marie Curie, during which he developed a high high-throughput microfluidic platform to study neuronal network calcium activity. He then did a Post-doctoral fellowship at CNRS, learning and optimizing microfluidic fabrication processes. He did a second post-doc at Columbia University (New York), where he worked on preventing the propagation of tauopathies in the CNS using microfluidic devices. He is now microfluidic scientist at HiFiBio, Paris.

Fanny Laroumanie defended in 2014 her thesis on the role of CD4+ T Lymphocytes in chronic heart failure. After her thesis she completed a post-doctoral fellowship at the University of Vanderbuilt, TN, USA, investigating the immune mechanisms responsible for aortic dissection. After her post-doc she decided to join the pharmaceutical company Astrazeneca as a medical science liaison in Immunology and Respiratory. She works on products’ lifecycle and helps create a link between the company and key scientists and clinicians.

Eugénie Martineau a soutenu en 2017 une thèse de microbiologie entre l’Université d’Aix Marseille et l’Université de Princeton. Lors d’un post-doctorat en microbiologie à L’Icahn School of Medicine at Mount Sinai, elle a développé des lignées de Lactobacillus spp pour moduler le microbiome vaginal et traiter les vaginoses bactériennes. Elle a ensuite fait un stage au sein des Mount Sinai Innovation Partners, où elle a appris comment amener les innovations thérapeutiques sur le marché. Depuis un an, elle travaille en tant que consultante santé au sein du cabinet de conseil Alcimed, spécialisé en innovation et développement de nouveaux marchés.

Charles Sanson a soutenu une thèse en neuroscience en 2017. A la suite de sa thèse, il s’est orienté vers le métier de consultant. A travers ses différentes expériences professionnelles, Charles a accompagné les start-up et les PME de la biotech/medtech afin de faciliter leur accès au marché, leur développement et leur processus d’innovation. Charles travaille depuis 1 an pour la communauté urbaine de Limoges, auprès des acteurs publics et parapublics, en tant que chargé de mission innovation territoriale.

Kevin Laouer (CFO) & Paul Cassé (CEO) ont tous les deux créé la start-up CAPS en 2018, avec Pierre de Chateaubourg (CTO). CAPS développe un engin volant autonome à un passager pour sa mobilité urbaine quotidienne, avec la technologie eVTOL (electric vertical takeoff and landing). En parallèle, Kevin Laouer fait un doctorat sur les multiscale folding dynamics of G-quadruplex DNA par dichroïsme circulaire résolue en temps à l’Ecole polytechnique.

Flavia Guillem a soutenu une thèse de génétique/biologie moléculaire en 2012 à l’hôpital Bichat. Après 5 années de post-doctorat au sein de l’Institut Imagine, Flavia s’est orientée dans le domaine de la recherche clinique. Dans cet univers, Flavia a très vite évolué et est aujourd’hui chef de projet en recherche clinique au sein de ClinSearch, une entreprise qui fournit des services de développement clinique et de commercialisation de dispositifs médicaux et de médicaments au niveau européen. Son travail consiste à manager des essais cliniques pour des industriels pharmaceutiques. 

Majid Touka a passé son doctorat en 2006. Après deux expériences de post doctorat en biologie cellulaire et moléculaire, il a déménagé au Royaume-Uni pour travailler chez Invitrogen (Life Technologies) en tant que vendeur spécialiste d’application scientifique. Après un an et demi, il est devenu chef d’équipe des ventes en Espagne, au Benelux et en France. Depuis 2013, en plus de ses précédentes missions, il s’occupe des comptes stratégiques de l’entreprise dans le Sud de la France.

Elodie Chabrol a obtenu sa thèse en neurogénétique en 2009. En parallèle de son post-doctorat à Londres, Elodie intègre en 2013 l’équipe fondatrice du plus grand festival de vulgarisation scientifique “Pint of Science” pour organiser la première édition en Angleterre. Après cela, elle fonde la version française dont la première édition voit le jour en 2014. Désormais, consultante en communication scientifique pour son propre compte, Elodie est la directrice internationale de “Pint of Science”, la créatrice du podcast “Sous la blouse” et la co-fondatrice de “Beyond Research”, une initiative à but non lucratif qui vise à aider les chercheurs et les innovateurs européens dans leur communication.

 

 

 

Saci Iken completed a PhD in Immunology at Pierre and Marie Curie University. He later became a technical sales engineer at Ozyme. After a good sales experience and a good growth, he evolved as Account Manager at Stemcell Technologies. He later specialized in cell sorting and immunology. He is now a technical sales specialist in the live cell analysis system at Sartorius, in charge of an Incucyte S3 capital investment project.

Charlotte Richard has a PhD in Developmental Biology at Pierre and Marie Curie University, and has an atypical profile. Indeed, following her thesis, she was later in charge of projects in scientific mediation in the PhD association in UPMC for more than 3 years. During 5 years, she was responsible for communication in cultural mediation. She is now in charge of scientific communication at the « Cancéropôle » of Ile de France.

Adrien François obtained his PhD in philosophy / neurophysiology from UPMC. During 3 years, he was a teacher-researcher in a university. He was then a research engineer at INRA. He is now a scientific police engineer, at the National Institute of Forensic Science, where he is responsible for the biology / genetic fingerprint section.

Shahul Mouhamad obtained his PhD at Paris Sud University. He subsequently completed a post doc at INSERM in the field of apoptosis, cancer and immunity. He has had many successive positions that allowed him to expand his skills in teaching. Indeed, after his post doc, he was a professor during 1 year at Sup’Biotech, 3 years at ENS Cachan, and 3 years at UPMC. He was then a researcher for 2 years and a professor again in Paris 7. He is now for more than 8 years product manager at Miltenyi Biotech.

Sebastian Lechner is a specialist in immunology and nephrology. He did his doctorate in the field of IgA nephrology. Subsequently, he completed a postdoctoral contract at INSERM for around 2 years confirming his specialization in immunology / nephrology. He is now medical science liaison in oncology at Astra Zeneca for over one year.

Jérôme Braudeau is a doctor in neuroscience, he specialized in preclinical pharmacology, especially in neurodegenerative diseases. He has acquired a solid expertise in characterization of therapies, with the aim of counteracting the natural evolution of various diseases such as Alzheimer’s disease, stroke and Down’s syndrome. He has started a new adventure in 2016 by creating the start-up AgenT. He is using his research on Alzheimer’s disease to develop the first blood diagnosis of the silent phase of AD to better treat patients.

 

Céline Curis is project manager at the Fondation Bettencourt-Schueller, where she is in charge of scientific philanthropy. She joined the Fondation Bettencourt-Schueller directly after completing her PhD in Virology at the Pasteur Institute. During her PhD, Céline also worked as a scientific mediator for Universcience.

Céline Giustranti is communication manager at Imagine Institute. After a PhD in molecular and cellular biology at Descartes university, she was communication manager at Curie Institute for scientific and medical information, and then as external communication manager. She is now working at Imagine institute to increase institute’s visibility.

Yoann Arthaud is expert in innovation at Alten. After his PhD in medical devices, he was a post-doc fellow at CEA. Then, he used to work at ministry of Foreign Office in charge of scientific mission before working in consulting at Leyton. He is now working since a few time as expert in innovation in the field of health and pharmacology.

Sébastien Paque is project engineer at the French Ministry of Agriculture. He completed a PhD in Vegetal Biology at the CNRS / Université Paris Sud, and then moved to the Wageningen University in the Netherlands where he worked as a Post-Doc. He recently joined the Directorate for Food, where he works of crop protection.

Abla Benleulmi-Chaachoua is a business development manager at Inserm Transfert. She did a PhD and a post-doc fellow in cellular pharmacology in collaboration with Servier company. Then, she used to work as key account manager at LaboGene ApS and she is now working at Inserm Transfert to promote academic projects in private companies.

 

 

Guillaume Rodriguez: Guillaume defended his PhD in Computational Neuroscience in 2016 and then obtained a position as a Scientific Mediator at the City of Sciences and Industry where he had, during his PhD, carried out a doctoral mission for two years. He participates in the design and animation of science workshops for school groups and the general public.

Aude Nyadanu: After studying at the engineering school Ecole Polytechnique, Aude did a PhD in Chemistry at Ecole Normal Superieure in Paris. She has just defended her PhD a few months ago and she is now a teacher at University of Paris-Est Marne-la-vallée. She is a member of the board of the French Institute for the patient’s experience. On this optic, she is the founder & CEO of Lowpital. This company is aimed to innovate collectively to improve the everyday life at the hospital for the patients and the health workers.

Thomas Landrain: Thomas first did a career in academia after graduating in Genetics from Ecole Normale Superieure in Paris and co-founded the first french synthetic biology lab at Genopole where he did his PhD. He is also the co-founder of PILI Bio, a start up that he directed during two years, which created the first renewable and safe inks to be biologically synthesised by bacteria. In the meanwhile Thomas has co-founded La Paillasse, the first french and world largest community lab that fosters open science and technology. Finally Thomas has recently co-founded Just one Giant Lab (JoGL), the first research and innovation laboratory operating as a distributed, open and massive mobilisation platform.

Lory Montout: Lory did all his studies in the field of bio-informatics and his PhD in structural biology at University of Paris Diderot. Since 2016, he is a consultant for the European Commission in Data science applied to Biology. Beside his consulting, he has also co-founded the company AZGUARD Cybersecurity & intelligence. He is now working as a free-lance data scientist, innovation director, and project manager and is directing Happy Dev, a network of self-employed workers.

Pierre Bauër: After graduating from the engineering school Ecole Normale Supérieure, Pierre did a PhD in the field of physics and biology at Pierre and Marie Curie University and in parallel a master of business administration (MBA) at « Collège des Ingenieurs ». Now, he is a project leader at the Curie Institute and a consultant in free-lance. He is also a member-expert in PhD consulting EU, which is a consulting firm specialized in the interface between industry and academic research.

Jennifer Sengenès Pascal: Jennifer completed studies in chemistry and a PhD in Molecular Biology at Pierre and Marie Curie University. After a first experience as a consultant in innovation financing, she did a master’s degree in Management of Technology and Innovation at Paris Dauphine University. Jennifer then joined DiamLite, when it was created, a company which develops fluorescent nanodiamonds used in bioimaging. Since 2014, she is project manager at PEP-Therapy, a start-up developing therapeutic peptides for cancer treatment.

 

 

Nicolas DOULET is Industrial Partnership Manager at Imagine Institute. He did his PhD in Paris at Cochin institute and then obtained a master degree in business. Then he used to work as a scientific officer in France Biotech and Orphanet. Now his work consist in promote fundamental scientific project of Imagine’s researchers to potential industrial partner.

Meena Murma is a Clinical Research associate. She did her PhD in Germany in Neurosciences, then she worked as a post doctoral fellow for 8 years at l’INAF, l’ENS and then l’INRA. She obtained her clinical research diploma at the Leonard de Vinci Institute and worked as a CRA at Necker Hospital.

Marion PILORGE is Business Developer at Imagine Institute. After a PhD in neurosciences and genetics, she obtained a master degree in management and worked during more than 2 years in Alcimed as a healthcare consultant before working in industrial partnership area.

Nouara LHOCINE is Grant Officer at Imagine Institute. She did her PhD in genetics in the Center of Molecular Genetics in Paris and worked as a postdoctoral fellow for 6 years at Pasteur institute and Imagine Institute. She is now working as a grant officer to promote fundamental scientific project with helping researchers.  

Aurélie LAUBIER is a DIM gene therapy project manager at Imagine Institute. She did her PhD in microbiology and immunology in Aix-Marseille CNRS lab. She did a master degree in management and innovation at ENS “Arts & Métiers” and worked during 2 years at Universal Biotech as health innovation project manager. She is now working for DIM gene therapy to promote fundamental project in this field.  

 

 

Guillaume Rodriguez: Guillaume defended his PhD in Computational Neuroscience in 2016 and then obtained a position as a Scientific Mediator at the City of Sciences and Industry where he had, during his PhD, carried out a doctoral mission for two years. He participates in the design and animation of science workshops for school groups and the general public.

Alix Rousseau: After a PhD in Hematology and Oncology at the Saint-Louis Hospital during which she got involved in the ADELIH association, she then joined Inovarion where she exercises the post of Buisness Developer since October, 2017.

Agathe Valluet-Paul: Strong of a double scientific (doctorate in oncology) and economic competence (specialized Master’s degree ESCP-EUROPE), Agathe is now Consultant at QuintilesIMS where she works on various consulting missions around the promotion of the medicine.

Romain Sikora: After his PhD in cellular biology and several years in different biomedical research institutes in Paris (Cochin and Curie), Romain has switched to clinical research and is now a Clinical Research Associate in oncology at Saint-Louis Hospital.

Mikhail Zaslavskiy: After a PhD at École des Mines of Paris in bioinformatics, he is now an Independent consultant in data science and bioinformatics and is also a study leader in the innovative start-up OWKIN specialized in machine learning applied to the medical research.

Marc Chevalier: Once Marc had obtained his PhD in Neuroscience, he decided to alternate between scientific positions and entrepreneurship while being involved in volunteer associations aiming at favouring communication between PhD Doctors and companies. He is now working as a Scientific Career Advisor at Institut Pasteur.

 

 

Rémy Rodriguez: After a thesis on human genetic immunodeficiencies at the Imagine Institute, Rémy works today at Novoptim as a consultant. Its activity allows the companies to have a follow up in the field of health via, among other things, market analyzes or sales pilot setting up.

Mathieu Ing: Directly after his PhD in Immunology realized at the Cordeliers Research Center (Paris), Mathieu Ing has been working since 2016 at DBV technologies as a researcher. He is in charge of research projects focusing on an epicutaneous immunotherapy that aims to deliver bioactive compounds to the immune system through intact skin.

Bruno Latgé: Holder of an engineering master degree from AgroParisTech and specialized in Biotechnology, Bruno did a PhD in Molecular and Cell Biology at Institut Curie. In January 2017, he co-founded the Curie In’C2 initiative (an awareness-raising initiative about technology transfer). He is now Business Developer at FINDMED, a Consortium to coordinate new R&D partnership contracts between French SMEs from the pharmaceutical industry and the Carnot institutes.

Isabelle Motta: Sorry, Isabelle will not be able to attend the professional breakfast. We are trying to find a replacement for her.

Maureen Alivon: Maureen obtained her PhD in clinical pharmacology in 2014 in which she followed classes about clinical trials and project management. She then worked at Servier as a global communication project leader and quickly evolved as a global communication manager where she is responsible for the organization of scientific events, international collaborations and post-marketing studies.

 

 

Emmanuel Pasco-Viel is Project Manager at the French Ministry for Higher Education and Research. Emmanuel did is PhD at the IGFL in Lyon, and then obtained a Masters degree in Research Administration. He is now in charge of several projects linked to the European Research Area (ERA).

Jérémy Scelle is Consultant in Innovation financing at F. Iniciativas, a company aiming to promote both research and innovation, and to create bonds between public and private research. He obtained a Masters degree and a PhD in Molecular Chemistry at the UPMC, and works at F. Iniciativas since 2017.

Amelie Dublineau will start a position of project coordinator at Institute Pasteur in mid-february 2018. She is in charge of an epidemiological study on Hepatitis C Virus in Egypt, thus her work will be based in Paris with missions in Cairo. After her PhD in Virology at the Pasteur Institute, she followed a training to become Clinical Research Associate and has worked on several studies in France as well as in Guinea and Malawi.

Elodie Touzé is a scientific mediator at Palais de la découverte where she participates in creating and animating conferences for general public as well as experimental workshops. After defending her PhD in Life Science 2007 in Strasbourg, she worked for several associations of scientific mediation oriented either more on theatre for kids or on experimental side. She also worked at Cité des enfants in Paris.

Alexey Rak is Head of Biostructure and Biophysics at Sanofi. He is a scientist with extensive industrial and academic experience. Before coming to Sanofi he was a principal investigator at Max Planck Institute of Molecular Physiology in Dortmund, Germany.

 

 

Amélie Petitprez
After a PhD in pharmaco-oncology obtained in 2012 in Paris Descartes university, Amelie became a scientific writer for Kephren. She then followed a training of clinical research associate and became the regional responsible for Hospira. She finally obtained a medical science liaison job at Jazz Pharmaceuticals where she currently works.

Mark Livingstone obtained his Ph.D. in Biochemistry in 2011 and completed it with a MBA at HEC. He reached an extensive international experience at the interface between academic research and the commercialization of scientific discoveries. He is currently Director, European Accounts at Scientist.com, a business which builds private marketplaces that simplify the purchase of research services.

Laurent Foiry
After he got phd in genetics at Paris Descartes University in 2006, during one year Laurent studied strategical management at HEC. After that he joined OTC Asset Management as a charge d’affaires before he founded SPRING Invest, an investment fund in retail, in 2015.

Morgane Montabrut
After obtaining her PhD at the CEA, Morgane followed an alternating training with Ozyme and UPMC in Health Marketing and a Master 2 in Sales Negotiations at UPMC. She then worked for 3 years as a sales engineer at Life Technologies and then became “Key Account Manager – consumables” at Thermo Fisher Scientific.

Thomas Ybert is the CEO and co-founder of DNA Script. He holds an engineering degree and a PhD from Ecole Polytechnique. Thomas spent 3 years in the biotechnology department at Sanofi R&D, where he developed a biotherapeutic production platform based on yeast technology. After 2 years spent in San Francisco Thomas came back to France to found DNA Script.

Registrations are now open:  REGISTRATION FORM